Assessing Bacterial Colonization in a Mouse Brain following Listeria monocytogenes Infection
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:18 min • July 8th, 2025
Loading...
Overview
This article demonstrates a protocol for quantifying the infective bacterial load of Listeria monocytogenes in the perfused mouse brain. The method involves careful tissue processing, selective plating, and colony counting to accurately assess bacterial burden in brain tissue following infection.
Key Study Components
Area of Science
- Microbiology
- Infectious Disease Research
- Neuroscience
Background
- Listeria monocytogenes is a pathogenic bacterium capable of infecting the brain.
- Quantifying bacterial load in brain tissue is essential for studying infection dynamics and host-pathogen interactions.
- Perfusion removes blood, ensuring that measurements reflect bacteria present in the brain tissue itself.
- Selective plating allows for the identification and quantification of antibiotic-resistant bacterial strains.
Purpose of Study
- To provide a reproducible protocol for measuring Listeria monocytogenes burden in mouse brain tissue.
- To ensure accurate quantification by removing blood and selectively culturing resistant bacteria.
- To facilitate studies on brain infection and bacterial pathogenesis.
Methods Used
- Perfusion of mice to remove blood from the brain.
- Dissection and transfer of the brain into cold PBS.
- Homogenization of brain tissue using a sterilized homogenizer.
- Preparation of tenfold serial dilutions of brain homogenate in sterile PBS.
- Plating of dilutions on brain heart infusion agar containing streptomycin.
- Incubation of plates at 37°C overnight.
- Counting of bacterial colonies to determine colony-forming units (CFU).
Main Results
- Successful isolation and quantification of streptomycin-resistant Listeria monocytogenes from mouse brain tissue.
- Accurate measurement of viable bacterial load as CFU per organ or per milliliter of blood.
- Demonstration of a reliable workflow for assessing brain infection in experimental models.
Conclusions
- The described protocol enables precise quantification of Listeria monocytogenes in perfused mouse brains.
- Perfusion and selective plating are critical for accurate assessment of tissue-specific bacterial burden.
- This method supports research into bacterial pathogenesis and host responses in the brain.
Frequently Asked Questions
Why is perfusion necessary before brain extraction?
Perfusion removes blood from the brain, ensuring that bacterial counts reflect only those bacteria present in the brain tissue, not in the blood.
What is the purpose of using streptomycin-resistant Listeria monocytogenes?
Using a streptomycin-resistant strain allows for selective growth and quantification of the bacteria on agar plates containing streptomycin, preventing contamination from other microbes.
How is the brain homogenized for bacterial quantification?
The brain is homogenized in cold PBS using a sterilized tissue homogenizer to break down the tissue and release bacteria for subsequent dilution and plating.
Why are serial dilutions prepared before plating?
Serial dilutions ensure that the number of colonies on the agar plates is countable and within a reliable range for accurate CFU determination.
How are colony-forming units (CFU) calculated?
After overnight incubation, colonies are counted on plates from appropriate dilutions, and the CFU per organ or per milliliter is calculated based on dilution factors.
What biosafety precautions are necessary during this protocol?
All tissue handling and homogenization steps should be performed in a biosafety cabinet, and equipment must be sterilized between samples to prevent cross-contamination and ensure safety.
Executive Industry Relevance
Quantifying bacterial colonization in perfused mouse brain tissue enables precise assessment of infection dynamics and tissue-specific pathogen burden. This workflow supports mechanistic de-risking in infectious disease models and informs target validation for host-pathogen interaction studies. Accurate bacterial load measurement is critical for translational research and portfolio decisions in anti-infective R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rigorous interrogation of infection hypotheses in disease-relevant brain tissue.
- Supports functional validation of host-pathogen interactions and immune response targets.
- Provides quantitative data for mechanistic de-risking and target confidence.
Screening & Assay Development
- Establishes a validated workflow for quantifying viable bacterial load in brain tissue.
- Facilitates assay reproducibility and standardization through selective plating and serial dilution.
- Generates quantitative outputs (CFU) suitable for downstream screening and comparative studies.
Translational & Preclinical Research
- Aligns infection models with disease-relevant tissue for translational biomarker development.
- Enables continuity from discovery through preclinical validation of anti-infective strategies.
- Supports risk-adjusted advancement decisions based on quantitative infection burden.
Pipeline & Workflow Integration
This method integrates into the infectious disease discovery continuum, from early hypothesis testing to preclinical model validation and translational research.
- Discovery Biology: Provides robust quantification for hypothesis testing and pathway clarification in brain infection models.
- Screening: Delivers standardized, reproducible CFU measurements for assay readiness and compound evaluation.
- Analytics: Enables quantitative comparison of bacterial burden across experimental conditions and interventions.
- Translational Research: Bridges discovery and preclinical phases by modeling infection in disease-relevant tissue.
- Enterprise Reuse: Offers a reusable protocol for diverse infection and tissue colonization studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in infection models.
- Operational Value: Standardizes bacterial quantification and enhances reproducibility across studies.
- Strategic Value: Informs go/no-go decisions and optimizes resource allocation in anti-infective portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of infection targets and therapeutic strategies.
Implementation Considerations
- Requires expertise in tissue dissection, perfusion, and sterile technique.
- Needs access to biosafety cabinets, tissue homogenizers, and selective agar plates.
- Demands rigorous cross-team standardization for reproducible CFU quantification.
- Adaptable to other tissue types and infection models with protocol modifications.
- Dependent on accurate serial dilution and colony counting for reliable outputs.
Biopharma FAQs
Why does null hypothesis testing matter for bacterial CFU quantification?
Null hypothesis testing ensures that observed differences in bacterial load are statistically significant, supporting robust target validation and reducing false positives in infection studies.
How does independent variable isolation fit the perfused brain infection workflow?
Isolating variables such as bacterial strain or treatment condition allows for clear attribution of changes in CFU to specific interventions, strengthening mechanistic insights and discovery pipeline decisions.
What do quantitative CFU measurements enable in infection model studies?
Quantitative CFU outputs provide objective metrics for comparing infection severity, evaluating intervention efficacy, and informing translational research strategies.
Why are replication requirements critical for cross-functional infection studies?
Replication ensures that CFU quantification is reproducible across teams and experiments, enabling reliable data integration and collaborative decision-making in R&D workflows.
Which statistical analysis capabilities are required before implementing CFU-based assays?
Robust statistical tools are needed to analyze CFU data, assess significance, and support data-driven advancement decisions in infection model development and screening.
10:10
Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Related Videos
0 Views
09:00
Precise, High-throughput Analysis of Bacterial Growth
Related Videos
0 Views
10:41
A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
Related Videos
0 Views
12:50
Measuring Bacterial Load and Immune Responses in Mice Infected with Listeria monocytogenes
Related Videos
0 Views
04:02
Detection of Target Gene Expression in a Bacteria-Infected Mouse Brain
Related Videos
0 Views
04:21
Quantifying Bacterial Load in the Mouse Heart Following Tail Vein Injection of Listeria monocytogenes
Related Videos
0 Views
08:38
Oral Transmission of Listeria monocytogenes in Mice via Ingestion of Contaminated Food
Related Videos
0 Views
09:18
Assessing Bacterial Invasion of Cardiac Cells in Culture and Heart Colonization in Infected Mice Using Listeria monocytogenes
Related Videos
0 Views
06:20
Detection of Enterohemorrhagic Escherichia Coli Colonization in Murine Host by Non-invasive In Vivo Bioluminescence System
Related Videos
0 Views
07:26
Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
Related Videos
0 Views
Last updated: 15 August 2026